Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search
TECHBIO-TECHNE Corp Live data
$72.51▼ -0.10 (-0.1%%)as of Sep 29, 2026, 1:54 AM UTC
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$43.20$72.69
Daily Price Range
Day down -0.1%%
$72.48$72.65
Volume
vs 3M avg
4M3M avg
Profile
Identity and capital structure
SectorEquity
IndustryCommon Stock
Market Cap$11.4B
Short % of Float—
Employees—
Sales—
Shares Outstanding156,805,958
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.tech.com
BIO-TECHNE Corp — Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also ….· via yahoo
Warnings
1 signal
Live
- No material red flags detected in fundamental screen
Scores
0–100 · higher is better except where noted
Value
—
Growth
—
Quality
—
Sentiment
—
Insider Sent.
—
Piotroski F
—
Altman Z
—
Consensus rating unavailable — no analyst coverage on file for TECH.
Price targets unavailable — no 12-month targets on file for TECH.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on TECH, calculate Margin of Safety, and stress-test WACC discount hurdles.
Data as ofQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedSep 29, 2026, 1:54 AM UTC